Saag MS - Search Results

1

Simoni JM, Nance RM, Whitney BM, Saag MS, Crane HM. Simoni JM, et al. Among authors: saag ms. Ann Intern Med. 2019 Apr 16;170(8):582-583. doi: 10.7326/L19-0067. Ann Intern Med. 2019. PMID: 30986840 No abstract available.

2

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al. Kappes JC, et al. Among authors: saag ms. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49. doi: 10.1097/00042560-199510020-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552477 Clinical Trial.

3

HIV viral load markers in clinical practice.

Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. Saag MS, et al. Nat Med. 1996 Jun;2(6):625-9. doi: 10.1038/nm0696-625. Nat Med. 1996. PMID: 8640545 Review.

4

Effect of antiretroviral therapy on plasma HIV RNA.

Saag MS. Saag MS. J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):105-6. J Biol Regul Homeost Agents. 1995. PMID: 8782017 Review. No abstract available.

5

Use of HIV viral load in clinical practice: back to the future.

Saag MS. Saag MS. Ann Intern Med. 1997 Jun 15;126(12):983-5. doi: 10.7326/0003-4819-126-12-199706150-00010. Ann Intern Med. 1997. PMID: 9182477 No abstract available.

6

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, Matthews T, Johnson MR, Nowak MA, Shaw GM, Saag MS. Kilby JM, et al. Among authors: saag ms. Nat Med. 1998 Nov;4(11):1302-7. doi: 10.1038/3293. Nat Med. 1998. PMID: 9809555 Clinical Trial.

7

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

Hockett RD, Kilby JM, Derdeyn CA, Saag MS, Sillers M, Squires K, Chiz S, Nowak MA, Shaw GM, Bucy RP. Hockett RD, et al. Among authors: saag ms. J Exp Med. 1999 May 17;189(10):1545-54. doi: 10.1084/jem.189.10.1545. J Exp Med. 1999. PMID: 10330433 Free PMC article.

8

Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.

Kilby JM, Goepfert PA, Miller AP, Gnann JW Jr, Sillers M, Saag MS, Bucy RP. Kilby JM, et al. Among authors: saag ms. Ann Intern Med. 2000 Sep 19;133(6):435-8. doi: 10.7326/0003-4819-133-6-200009190-00011. Ann Intern Med. 2000. PMID: 10975961 Review.

9

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.

Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ. Bedimo R, et al. Among authors: saag ms. Clin Infect Dis. 2004 Nov 1;39(9):1380-4. doi: 10.1086/424883. Epub 2004 Oct 11. Clin Infect Dis. 2004. PMID: 15494916

10

Sustained HIV viral suppression following treatment interruption: an observational study.

Bedimo R, Chen RY, Westfall AO, Raper JL, Allison JJ, Saag MS. Bedimo R, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 2006 Jan;22(1):40-4. doi: 10.1089/aid.2006.22.40. AIDS Res Hum Retroviruses. 2006. PMID: 16438644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters